These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2986019)

  • 1. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastric H+,K+-ATPase: the site of action of omeprazole.
    Sachs G; Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substituted benzimidazole, inhibiting substance of K+/H+ ATPase of parietal cells--a new principle in the treatment of peptic ulcer].
    Sewing KF
    Internist (Berl); 1983 Dec; 24(12):680-3. PubMed ID: 6319314
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of omeprazole.
    Wallmark B
    Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles.
    Beil W; Sewing KF
    Br J Pharmacol; 1984 Jul; 82(3):651-7. PubMed ID: 6146367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisecretagogues and parietal cells.
    Sewing KF
    Agents Actions; 1984 Apr; 14(3-4):319-24. PubMed ID: 6328950
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of the proton pump with omeprazole. A new principle of ulcer therapy?].
    Müller P; Dammann HG; Seitz H; Simon B
    MMW Munch Med Wochenschr; 1983 May; 125(21):459-60. PubMed ID: 6308432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
    Yamamoto O; Tanaka H; Ueda F; Kimura K
    Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells.
    Busque SM; Kerstetter JE; Geibel JP; Insogna K
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G664-9. PubMed ID: 15961860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
    Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of the gastric acid secretion inhibitor omeprazole.
    Lindberg P; Nordberg P; Alminger T; Brändström A; Wallmark B
    J Med Chem; 1986 Aug; 29(8):1327-9. PubMed ID: 3016260
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
    Kromer W; Gönne S; Riedel R; Postius S
    Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.